Here we report that PR1-specific CTL are increased and persist in the peripheral blood of CML patients during unmaintained CCR after stopping IFN and that PR1-CTL secrete IFNγ. This evidence concerns the gene TMEM37 and chronic myelogenous leukemia, BCR-ABL1 positive.